Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,700
Closed -$203K 4570
2024
Q4
$203K Hold
16,700
﹤0.01% 4080
2024
Q3
$281K Hold
16,700
﹤0.01% 4009
2024
Q2
$261K Buy
+16,700
New +$232K ﹤0.01% 3963
2014
Q2
Sell
-22,800
Closed -$384K 4414
2014
Q1
$384K Sell
22,800
-40,000
-64% -$654K ﹤0.01% 3787
2013
Q4
$1.08M Buy
+62,800
New +$1.09M ﹤0.01% 3107

Other funds holding NEOG

David Shaw's NEOG Position: Q2 2026 in Review

David Shaw opened a new position in Neogen (NEOG) in Q2 2026: 42,499 shares worth $382K. The stake represents ﹤0.01% of the portfolio and ranks #4308 among its holdings. This is a return to the name: David Shaw previously reported a position in NEOG as recently as Q4 2025.

David Shaw first reported a position in NEOG in Q3 2015 and has held it in 30 quarters since. The position peaked at $23.5M in Q2 2023. 314 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • David Shaw held 42,499 shares of Neogen worth $382K as of Q2 2026.
  • Neogen was a new David Shaw position in Q2 2026.
  • Neogen made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4308 holding.
  • David Shaw first reported a position in Neogen in Q3 2015 and has held it in 30 quarters since.
  • David Shaw's Neogen position peaked at $23.5M in Q2 2023.
  • 314 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.